New Risk • Mar 23
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 110% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). High level of non-cash earnings (31% accrual ratio). Shareholders have been substantially diluted in the past year (110% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹4.05b market cap, or US$43.3m). 공시 • Mar 23
Dhariwal Corp Limited has completed a Follow-on Equity Offering in the amount of INR 117.5175 million. Dhariwal Corp Limited has completed a Follow-on Equity Offering in the amount of INR 117.5175 million.
Security Name: Equity Shares
Security Type: Common Stock
Securities Offered: 47,007,000
Price\Range: INR 2.5
Transaction Features: Rights Offering Valuation Update With 7 Day Price Move • Feb 27
Investor sentiment deteriorates as stock falls 43% After last week's 43% share price decline to ₹41.80, the stock trades at a trailing P/E ratio of 47.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 97% over the past year. 공시 • Nov 14
Dhariwal Corp Limited to Report First Half, 2026 Results on Nov 14, 2025 Dhariwal Corp Limited announced that they will report first half, 2026 results on Nov 14, 2025 Valuation Update With 7 Day Price Move • Jul 25
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹174, the stock trades at a trailing P/E ratio of 37.1x. Average trailing P/E is 29x in the Chemicals industry in India. 공시 • Jul 14
Dhariwal Corp Limited, Annual General Meeting, Aug 07, 2025 Dhariwal Corp Limited, Annual General Meeting, Aug 07, 2025, at 12:30 Indian Standard Time. Location: g-764 boranada industrial area, iv phase, rajasthan - 342012., jodhpur India New Risk • Jul 13
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.5% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Market cap is less than US$100m (₹1.34b market cap, or US$15.7m). New Risk • Jun 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10.0% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Market cap is less than US$100m (₹1.32b market cap, or US$15.4m). Valuation Update With 7 Day Price Move • May 13
Investor sentiment improves as stock rises 33% After last week's 33% share price gain to ₹142, the stock trades at a trailing P/E ratio of 30.1x. Average trailing P/E is 25x in the Chemicals industry in India. New Risk • Mar 11
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹899.6m (US$10.3m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Market cap is less than US$10m (₹899.6m market cap, or US$10.3m). Valuation Update With 7 Day Price Move • Mar 11
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₹91.25, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 25x in the Chemicals industry in India. New Risk • Feb 12
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.2% average weekly change). Minor Risk Market cap is less than US$100m (₹1.11b market cap, or US$12.8m). New Risk • Jan 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.5% average weekly change). Market cap is less than US$100m (₹1.24b market cap, or US$14.5m). Reported Earnings • Nov 15
First half 2025 earnings released First half 2025 results: EPS: ₹3.68. Net income: ₹26.8m (up ₹26.8m from 1H 2024). Valuation Update With 7 Day Price Move • Aug 22
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹165, the stock trades at a trailing P/E ratio of 32.8x. Average trailing P/E is 35x in the Chemicals industry in India.